PET and SPECT Imaging of Brain Tumors

Area of Science:

• Radiology and Nuclear Medicine
• Oncology
• Medical Imaging Analysis

Background:

• Neuroimaging is crucial for brain tumor diagnosis, treatment planning, and prognosis.
• Evolving cancer treatments necessitate complex imaging interpretation.
• Combining data from multiple imaging techniques (CT, MRI, nuclear medicine) improves diagnostic accuracy.

Purpose of the Study:

• To review current brain tumor imaging strategies.
• To detail the application of nuclear medicine in neuro-oncology.
• To explore the use of various radiotracers in tumor evaluation.

Main Methods:

• Review of current literature on brain tumor imaging.
• Focus on single-photon emission computed tomography (SPECT) and positron emission tomography (PET).
• Discussion of common and uncommon radiotracers used in nuclear medicine brain tumor imaging.

Main Results:

• Nuclear medicine imaging, particularly PET and SPECT, offers valuable insights into tumor characteristics.
• Radiotracer selection impacts the effectiveness of tumor grading, diagnosis, and treatment response assessment.
• Multimodality imaging integration provides a comprehensive evaluation of brain tumors.

Conclusions:

• Nuclear medicine plays a significant role in the multimodal assessment of brain tumors.
• The strategic use of specific radiotracers enhances diagnostic and prognostic capabilities.
• Advanced imaging techniques are essential for optimizing patient management and treatment strategies in neuro-oncology.